Biological evaluation of mitomycin C bound to a biodegradable polymeric carrier

Journal of Controlled Release

Volumn 47, Issue 1, 1997, Pages 71-80

  Soyez, Heidi ^a   Schacht, Etienne ^a   Jelinkova, Marketa ^b   Rihova, Blanka ^b  

^a GHENT UNIVERSITY   (Belgium)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Biocompatibility; Calcium influx; Cytotoxicity; Macromolecular prodrug; Mitomycin C

Indexed keywords

MITOMYCIN C; MITOMYCIN DERIVATIVE; PRODRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG CONJUGATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SPLEEN CELL; T CELL LYMPHOMA; THYMOMA;

EID: 0030953525     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01617-3     Document Type: Article

References (43)

1. D.G. Walter and C.F. George, Prodrugs. Br. J. Clin. Pharmacol. (1989) 497-507.
2. R. Duncan, Drug-polymer conjugates: potential for improved chemotherapy. Anti-Cancer Drugs 3 (1992) 175-210.
3. D. Putnam and J. Kopecek, Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122 (1995) 55-123.
4. H. Maeda and M. Matsumura, Tumouritropic and lysosomotropic principles of macromolecular drugs. CRC Crit. Rev. Ther. Drug Carrier Sys. 6 (1989) 193-210.
5. H. Maeda, SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 6 (1991) 181-202.
6. L.W. Seymour, Passive tumour targeting of soluble macromolecules and drug conjugates. Crit. Rev. Ther. Drug Carrier Sys. 9 (1992) 135-187.
7. T.A. Connors and R.J. Knox, Prodrugs in cancer chemotherapy. Stem Cells 13 (1995) 501-511.
8. R. Duncan, H. Cable, J. Lloyd, P. Rejmanova and J. Kopecek, Degradation of side chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol proteases. Biosci. Rep. 2 (1981) 1041-1046.
9. V. Subr, J. Kopecek and R. Duncan, Degradation of oligopeptide sequences connecting poly[N-(2-hydroxypropyl)methacrylamide] chains by lysosomal cysteine proteinases. J. Bioact. Compat. Pol. 1 (1986) 133-146.
10. V. Subr, J. Strohalm, K. Ulbrich, R. Duncan and I. Hume, Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of daunomycin and adriamycin from poly[N-(2-hydroxypropyl)methacrylamide] copolymer drug carriers in vitro and antitumour activity measured in vivo. J. Control. Release. 18 (1992) 123-132.
11. A. De Marre, H. Soyez and E. Schacht, Synthesis of macromolecular Mitomycin C derhatives. J. Control. Release 32 (1994) 129-137.
12. A. De Marre, L.W. Seymour and E. Schacht, Evaluation of the hydrolytic and enzymatic stability of macromolecular Mitomycin C derivatives. J. Control. Release 31 (1994) 89-97.
13. A. Gerola, G. Antoni, F. Benvenuti, F. Cocola and P. Neri, in: Shock: Biochemical. Pharmacological and Clinical Aspects, Plenum Press, New York, 1970, pp. 329.
14. F. Rypacek, V. Saudek, J. Pytela, V. Skarda and J. Drobnik, Polyglutamines: versatile biodegradable carriers. Makromol. Chem. Suppl. 9 (1985) 129-135.
15. J. Pytela, V. Saudek, J. Drobnik and F. Rypacek. Poly(N-hydroxyalkylglutamines). IV. Enzymatic degradation of N(2-hydroxyethyl)-L-glutamine homopolymers and copolymers. J. Control. Release 12 (1989) 17-25.
16. A. De Marre, H. Soyez, E. Schacht, M.A. Shoaibi, L.W. Seymour and B. Rihova. Synthesis and evaluation of macro-molecular prodrugs of Mitomycin C. J. Control. Release 32 (1995) 87-97.
17. H. Soyez, E. Schacht, A. De Marre, L.W. Seymour, Polymeric prodrugs of Mitomycin C. Macromol. Symp. 103 (1996) 163-176.
18. L.W. Seymour, H. Soyez, A. De Marre, M.A. Shoaibi and E. Schacht, Improved anticancer efficacy and decreased toxicity for Mitomycin C linked to a soluble synthetic polymer. Anti-Cancer Drug Design 11 (1996) 351-365.
19. M.E. Cardenas and J. Heitman, Role of calcium in T-lymphocyte activation. Adv. Sec. Messenger Phosphoprotein Res. 30 (1995) 281-298.
20. E. Donnadieu, G. Bismuth and A. Trautmann, Calcium fluxes in T lymphocytes. J. Biol. Chem. 267, 25864-25872.
21. J. Braun and E.R. Uanue, Calcium and lymphocyte surface macromolecules, in: L.J. Anghileri and A.-M. Tuffet-Anghileri (Eds.). The Role of Calcium in Biological Systems, CRC Press, Boca Raton, Florida, 1982, pp. 175-186.
22. R.Y. Tsien, New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis and properties of prototype structures. Biochemistry 19 (1980) 2396-2404.
23. 2+ and membrane potential in lymphocytes. Nature 295 (1982) 68-71.
24. R.Y. Tsien, T. Pozzan and R.J. Rink, Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J. Cell Biol. 94 (1982) 325-334.
25. J.P.Y Kao, A.T. Harootunian and R.Y. Tsien, Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J. Biol. Chem. 264 (1989) 8179-8184.
26. S.K. Carter and S.T. Crooke, Mitomycin C: Current Status and New Developments, Academic Press. New York, 1979.
27. A. Goodman Gilman, L.S. Goodman and A. Oilman. The Pharmacological Basis of Therapeutics. Macmillan. New York, 1980.
28. D.R. Parks, V.M. Bryan, V.T. Oi and L.A. Herzenberg, Antigen-specific identification and cloning of hybridomas with a fluorescence activated cell sorter. Proc. Natl. Acad. Sci. USA 76 (1979) 1962-1966.
29. J.E. Till and E.A. McCulloch, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14 (1961) 213-222.
30. RETIC Count Kit, Beckton Dickenson Immunocytometry Systems.
31. R. Duncan, L.W. Seymour, K. O'Hara, P. Flanagan, S. Wedge, I. Hume, K. Ulbrich, J. Strohalm, V. Subr, F. Spreafico, M. Crandi, M. Ripamonti, M. Farao and A. Suarato, Preclinical evaluation of polymer-bound doxorubicin. J. Control, Release 19 (1992) 331-346.
32. R. Duncan, I. Hume, P. Kopecova, K. Ulbrich and J. Kopecek, Anticancer agents coupled to N-(2-hydroxpropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates in vivo against L 1210 leukemia in vivo. J. Control. Release 10 (1989) 51-63.
33. M. Sela, Immunological studies with synthetic polypeptides. Adv. Immunol. 5 (1966) 29-129.
34. M. Sela, Antigenicity: some molecular aspects. Science 166 (1969) 1365-1374.
35. B. Rihova and I. Riha, Immunological problems of polymerbound drugs. CRC Crit. Rev. Ther. Drug Carrier Sys. 1 (1985) 311-374.
36. C.J.T. Hoes, J. Grootoonk, R. Duncan, I.C. Hume, M. Bhakoo, J.M.W. Bouma and J. Feijen, Biological properties of adriamycin bound to biodegradable polymeric carriers. J. Control. Release 23 (1993) 37-54.
37. B. Rihova, K. Ulbrich, J. Kopecek and P. Mancal, The immunogenicity of N-(2-hydroxypropyl)methacrylamide copolymers-potential hapten of drug carriers. Folia Microbiol. 28 (1983) 217-227.
38. B. Rihova, M. Bilej, V. Vitvicka, K. Ulbrich, J. Strohalm, J. Kopecek and R. Duncan, Biocompatibility of N-(2-hydroxypropyl)methacrylamide copolymers containing adriamycin. Biomaterials 10 (1989) 335-342.
39. C.W. Parker. Correlation between mitogenicity and stimulation of calcium uptake in human lymphocytes. Biochem. Biophys. Res. Commun. 61 (1974) 1180-1186.
40. B. Rihova, P. Kopeckova, J. Strohalm, P. Rossmann, V. Vetvicka and J. Kopecek, Antibody-directed affinity therapy applied to immune system. In vivo effectiveness and limited toxicity of daunomycin conjugated to N-(2-hydroxypropyl)methacrylamide copolymers and targeting antibody. Clin. Immunol. Immunopathol. 46 (1988) 100-114.
41. L.G. Lu, C.H. Chen and L.A. Chiu, Thiazole Orange: a new dye for reticulocyte analysis. Cytometry 7 (1986) 508-517.
42. B.H. Sage, J.P. O'Connell and T.J. Mercolino, A rapid, vital staining procedure for flow cytometric analysis of human reticulocytes, Cytometry 4 (1983) 422-427.
43. H.J. Tanke, P.H. Rothbarth, J.M.J.J. Vossen, G.J.M. Koper and J.S. Ploem, Flow cytometry of reticulocytes applied to clinical hematology. Blood 61 (1983) 1091-1097.